BACKGROUND: Therapeutic hypothermia is a promising neuroprotective therapy with multiple mechanisms of action. We demonstrated the feasibility of thrombolysis combined with endovascular hypothermia, but not all patients achieved effective cooling. We sought to identify the factors that determined effective cooling. METHODS: In 26 patients who underwent endovascular hypothermia, we computed four measures of effective cooling: time to reach target; Area-Under-the-Curve (AUC) 34 ratio; AUC-34; and AUC-35. By multivariate regression, we examined the effects of age, weight, starting temperature, body mass index, body surface area (BSA), gender, shivering, and total meperidine dose on the four outcome measures. RESULTS: In univariate analyses, all four outcome measures were significantly influenced by BSA (p < 0.01 in all univariate analyses). Time to reach target temperature was quicker in older patients (p < 0.01). Shivering and meperidine dose were highly intercorrelated (r = 0.6, p < 0.01) and both marginally influenced all four outcome measures. In multivariate analysis, AUC ratio and time to reach target temperature were significantly influenced by BSA (p < 0.01) and meperidine (p < 0.05); AUC-34 was influenced only by BSA (p < 0.01). The AUC-35 was influenced by BSA (p < 0.01), shivering, and total meperidine dose (p < 0.05). CONCLUSIONS: The most important determinant of effective cooling during endovascular hypothermia is BSA; larger patients are more difficult to cool and maintain in therapeutic range. Older patients cool more quickly. Shivering was well controlled by the combination of meperidine, buspirone, and surface counter-warming and only minimally influenced cooling effectiveness. Future trials of therapeutic hypothermia may include added measures to cool larger patients more effectively.
RCT Entities:
BACKGROUND: Therapeutic hypothermia is a promising neuroprotective therapy with multiple mechanisms of action. We demonstrated the feasibility of thrombolysis combined with endovascular hypothermia, but not all patients achieved effective cooling. We sought to identify the factors that determined effective cooling. METHODS: In 26 patients who underwent endovascular hypothermia, we computed four measures of effective cooling: time to reach target; Area-Under-the-Curve (AUC) 34 ratio; AUC-34; and AUC-35. By multivariate regression, we examined the effects of age, weight, starting temperature, body mass index, body surface area (BSA), gender, shivering, and total meperidine dose on the four outcome measures. RESULTS: In univariate analyses, all four outcome measures were significantly influenced by BSA (p < 0.01 in all univariate analyses). Time to reach target temperature was quicker in older patients (p < 0.01). Shivering and meperidine dose were highly intercorrelated (r = 0.6, p < 0.01) and both marginally influenced all four outcome measures. In multivariate analysis, AUC ratio and time to reach target temperature were significantly influenced by BSA (p < 0.01) and meperidine (p < 0.05); AUC-34 was influenced only by BSA (p < 0.01). The AUC-35 was influenced by BSA (p < 0.01), shivering, and total meperidine dose (p < 0.05). CONCLUSIONS: The most important determinant of effective cooling during endovascular hypothermia is BSA; larger patients are more difficult to cool and maintain in therapeutic range. Older patients cool more quickly. Shivering was well controlled by the combination of meperidine, buspirone, and surface counter-warming and only minimally influenced cooling effectiveness. Future trials of therapeutic hypothermia may include added measures to cool larger patients more effectively.
Authors: D W Krieger; M A De Georgia; A Abou-Chebl; J C Andrefsky; C A Sila; I L Katzan; M R Mayberg; A J Furlan Journal: Stroke Date: 2001-08 Impact factor: 7.914
Authors: Seetha Shankaran; Athina Pappas; Abbott R Laptook; Scott A McDonald; Richard A Ehrenkranz; Jon E Tyson; Michelle Walsh; Ronald N Goldberg; Rosemary D Higgins; Abhik Das Journal: Pediatrics Date: 2008-10 Impact factor: 7.124
Authors: Sven Poli; Jan Purrucker; Miriam Priglinger; Marek Sykora; Jennifer Diedler; André Rupp; Cem Bulut; Werner Hacke; Christian Hametner Journal: Neurocrit Care Date: 2014-02 Impact factor: 3.210
Authors: Michael L James; Nicholas D Andersen; Madhav Swaminathan; Barbara Phillips-Bute; Jennifer M Hanna; Gregory R Smigla; Michael E Barfield; Syamal D Bhattacharya; Judson B Williams; Jeffrey G Gaca; Aatif M Husain; G Chad Hughes Journal: J Thorac Cardiovasc Surg Date: 2013-04-11 Impact factor: 5.209
Authors: Ignacio M Larrayoz; Manuel Rey-Funes; Daniela S Contartese; Federico Rolón; Anibal Sarotto; Veronica B Dorfman; Cesar F Loidl; Alfredo Martínez Journal: PLoS One Date: 2016-08-24 Impact factor: 3.240
Authors: Zhijuan Cao; Adithya Balasubramanian; Steen E Pedersen; Jonathan Romero; Robia G Pautler; Sean P Marrelli Journal: Sci Rep Date: 2017-12-15 Impact factor: 4.379